Hemodynamic-guided V-A ECMO management for cardiogenic shock: Insight from initial experience from TWEET study (to wean an ECMO trials)

Angelo Nascimbene, Sinan Tosun, Sriram Nathan, Harish Devineni, Ismael A. Salas de Armas, Xiaoqian Jiang, Lisa Janowiak, Kayla Kutilek, Jayeshkumar Patel, Manish K. Patel, Jiangxia Wang, Igor D. Gregoric, Biswajit Kar, Department of Advanced Cardiopulmonary Therapies and Transplantation, McGovern Medical School, University of Texas Health Science Center at Houston , Department of Health Data Science and Artificial Intelligence, University of Texas Health Science Center at Houston , Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University

Perfusion

Published online on June 12, 2026

Abstract

Perfusion, Ahead of Print.
BackgroundVeno-arterial extracorporeal membrane oxygenation (V-A ECMO) is used for refractory cardiogenic shock, yet optimal weaning strategies and the role of left ventricular (LV) venting remain unclear. The TWEET-1 study was designed as an early ...